Pitt Street Research is run by Stuart Roberts (one of the authors of this report) who is a well-known two-decade veteran of the Australian biotech industry. He previously worked as a biotech analyst at a couple of leading broking firms.
You pay for coverage by Pitt Street Research. It fills the void in coverage of smaller biotechs by the well-known sell-side analysts.
A then-unloved Neuren commissioned coverage by Pitt Street Research back in late 2018 for this very reason.
https://lifesciencessummit.co.nz/speaker/stuart-roberts/
Daily happenings?., page-274
-
- There are more pages in this discussion • 260 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
